NEW YORK, Aug. 10, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities of Nymox Pharmaceutical Corporation ("Nymox" or the
"Company") (NASDAQ: NYMX). Such investors are advised to contact
Peretz Bronstein or his investor
relations analyst, Yael Hurwitz at
info@bgandg.com or 212-697-6484.
The investigation concerns whether Nymox and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On August 10, 2016, Seeking
Alpha issued an article entitled "Nymox: This Offshore
'Biotech' Promotion Will Go To Zero (Yes, Zero)", in which it
stated that Nymox's administration is constantly deceiving
shareholders about Nymox's projections while "aggressively
dump[ing] stock without timely SEC disclosure." Following
this news, Nymox stock dropped as much as $1.47 per share, or 47.27%, to $1.64 during intraday trading on August 10, 2016.
If you purchased Nymox shares or if you are aware of any facts
relating to this investigation, you can assist this investigation
by visiting the firm's site: http://www.bgandg.com/nymx. You
can also contact Peretz Bronstein or
his Investor Relations Analyst, Yael
Hurwitz of Bronstein, Gewirtz & Grossman, LLC:
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-nymox-pharmaceutical-corporation-nymx-300312051.html
SOURCE Bronstein, Gewirtz & Grossman, LLC